Vitamin K epoxide reductase (VKORC1) gene mutations in osteoporosis: A pilot study

Translational Research

Volumn 156, Issue 1, 2010, Pages 37-44

  Holzer, Gerold ^a   Grasse, Anna Verena ^a   Zehetmayer, Sonja ^b   Bencur, Peter ^a   Bieglmayer, Christian ^a   Mannhalter, Christine ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b KONRAD LORENZ INSTITUTE FOR ETHOLOGY   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; MENADIONE EPOXIDE; OSTEOCALCIN; VITAMIN K GROUP;

ADULT; AGED; ALLELE; ARTICLE; COHORT ANALYSIS; CORRELATION ANALYSIS; DNA POLYMORPHISM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FRACTURE; GENE; GENE MUTATION; GENETIC VARIABILITY; GENOTYPE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; OSTEOPOROSIS; PILOT STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; VITAMIN K EPOXIDE REDUCTASE GENE;

EID: 77953600231     PISSN: 19315244     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trsl.2010.05.005     Document Type: Article

References (38)

1. Williams F.M., and Spector T.D. Recent advances in the genetics of osteoporosis. J Musculoskelet Neuronal Interact 6 (2006) 27-35
2. Morita A., Iki M., Dohi Y., et al. Prediction of bone mineral density from vitamin D receptor polymorphisms is uncertain in representative samples of Japanese Women. The Japanese Population-based Osteoporosis (JPOS) Study. Int J Epidemiol 33 (2004) 979-988
3. Thakkinstian A., D'Este C., and Attia J. Haplotype analysis of VDR gene polymorphisms: a meta-analysis. Osteoporos Int 15 (2004) 729-734
4. Zajickova K., and Zofkova I. Osteoporosis: genetic analysis of multifactorial disease. Endocr Regul 37 (2003) 31-44
5. Liu Y.Z., Liu Y.J., Recker R.R., and Deng H.W. Molecular studies of identification of genes for osteoporosis: the 2002 update. J Endocrinol 177 (2003) 147-196
6. Ralston S.H. Genetics of Osteoporosis. Proc Nutr Soc 66 (2007) 158-165
7. Zittermann A. Effects of vitamin K on calcium and bone metabolism. Curr Opin Clin Nutr Metab Care 4 (2001) 483-487
8. Szulc P., Seeman E., and Delmas P.D. Biochemical measurements of bone turnover in children and adolescents. Osteoporos Int 11 (2000) 281-294
9. Vergnaud P., Garnero P., Meunier P.J., Bréart G., Kamihagi K., and Delmas P.D. Undercarboxylated osteocalcin measured with a specific immunoassay predicts hip fracture in elderly women: the EPIDOS study. J Clin Endocrinol Metab 82 (1997) 719-724
10. Lian J., Stewart C., Puchacz E., et al. Structure of the rat osteocalcin gene and regulation of vitamin D-dependent expression. Proc Natl Acad Sci U S A 86 (1989) 1143-1147
11. Weber P. Vitamin K and Bone Health. Nutrition 17 (2001) 880-887
12. Szulc P., Chapuy M.C., Meunier P.J., and Delmas P.D. Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture in elderly women. J Clin Invest 91 (1993) 1769-1774
13. Iwamoto J., Takeda T., and Sato Y. Effects of vitamin K2 on osteoporosis. Curr Pharm Des 10 (2004) 2557-2576
14. Tsugawa N., Shiraki M., Suhara Y., et al. Low plasma phylloquinone concentration is associated with high incidence of vertebral fracture in Japanese women. J Bone Miner Metab 26 (2008) 79-85
15. Knapen M.H., Schurgers L.J., and Vermeer C. Vitamin K2 supplementation improves hip bone geometry and bone strength indices in postmenopausal women. Osteoporos Int 18 (2007) 963-972
16. Braam A.J.M.L., Knapen M.H.J., Geusens P., et al. Vitamin K supplementation retards bone loss in postmenopausal women between 50 and 60 years of age. Calcif Tissue Int 73 (2003) 21-26
17. Cockayne S., Adamson J., Lanham-New S., Shearer M.J., Gilbody S., and Torgerson D.J. Vitamin K and the prevention of fractures: systematic review and meta-analysis of randomized controlled trials. Arch Intern Med 166 (2006) 1256-1261
18. Binkley N., Harke J., Krueger D., et al. Vitamin K treatment reduces undercarboxylated osteocalcin but does not alter bone turnover, density or geometry in healthy postmenopausal North American women. J Bone Miner Res 24 (2009) 983-991
19. Booth S.L., Dallal G., Shea M.K., Gundberg C., Peterson J.W., and Dawson-Hughes B. Effect of vitamin K supplementation on bone loss in elderly men and women. J Clin Endocrinol Metab 93 (2008) 1217-1223
20. Cheung A.M., Tile L., Lee Y., et al. Vitamin K supplementation in postmenopausal women with osteopenia (ECKO trial): a randomized controlled trial. PLoS Med 5 (2008) e196. Erratum in: PLoS Med 5:e247
21. Rost S., Fergin A., Ivaskevicius V., et al. Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2. Nature 427 (2004) 537-541
22. Geisen G., Watzka M., Sittinger K., et al. VKORC1 haplotypes and their impact on the inter-individual and inter-ethnical variability of oral anticoagulation. Thromb Haemost 94 (2005) 773-779
23. Yuan H.Y., Chen J.J., Lee M.T.M., et al. A novel functional VKORC1 promoter polymorphism is associated with inter-individual and inter-ethnic differences in warfarin sensitivity. Hum Mol Genet 14 (2005) 1745-1751
24. D'Andrea G., D'Ambrosio R.L., Di Perna P., et al. A polymorphism in the VKORC1 gene is associated with an interindividual variability in the dose-anticoagulant effect of warfarin. Blood 105 (2005) 645-649
25. Kanis J.A., Devogelaer J.P., and Gennari C. Practical guide for the use of bone mineral measurements in the assessment of treatment of osteoporosis. Osteoporos Int 6 (1996) 256-261
26. Rust S., Funke H., and Assmann G. Mutagenically separated PCR (MS-PCR): a highly specific one step procedure for easy mutation detection. Nucleic Acids Res 21 (1993) 3623-3629
27. 1 in plasma, with fluorometric detection. Clin Chem 32 (1986) 1925-1929
28. Sun Y.M., Jin D.Y., Camire R.M., and Stafford D.W. Vitamin K epoxide reductase significantly improves carboxylation in a cell line overexpressing factor X. Blood 106 (2005) 3811-3815
29. Hallgren K.W., Qian W., Yakubenko A.V., Runge K.W., and Berkner K.L. r-VKORC1 expression in factor IX BHK cells increases the extent of factor IX carboxylation but is limited by saturation of another carboxylation component or by a shift in the rate-limiting step. Biochemistry 45 (2006) 5587-5598
30. Shearer M.J. Role of vitamin K and Gla proteins in the pathophysiology of osteoporosis and vascular calcification. Curr Opin Clin Nutr Metab Care 3 (2000) 433-438
31. Booth S.L., Martini L., Peterson J.W., Saltzman E., Dallal G.E., and Wood R.J. Dietary phylloquinone depletion and repletion in older women. J Nutr 133 (2003) 2565-2569
32. Preusch P.C., and Suttie J.W. Relationship of dithiothreitol-dependent microsomal vitamin K quinone and vitamin K epoxide reductases inhibition of epoxide reduction by vitamin K quinone. Biochim Biophys Acta 798 (1984) 141-143
33. Booth S.L., Broe K.E., Peterson J.W., et al. Associations between vitamin K biochemical measures and bone mineral density in men and women. J Clin Endocrinol Metab 89 (2004) 4904-4909
34. Wang Y., Zhang W., Zhang Y., et al. VKORC1 haplotypes are associated with arterial vascular diseases (stroke, coronary heart disease, and aortic dissection). Circulation 113 (2006) 1615-1621
35. Wang D., Chen H., Momary K.M., Cavallari L.H., Johnson J.A., and Sadee W. Regulatory polymorphism in vitamin K epoxide reductase complex subunit 1 (VKORC1) affects gene expression and warfarin dose requirement. Blood 112 (2008) 1013-1021
36. Sasaki N., Kusano E., Takahashi H., et al. Vitamin K2 inhibits glucocorticoid-induced bone loss partly by preventing the reduction of osteoprotegerin (OPG). J Bone Miner Metab 23 (2005) 41-47
37. Spohn G., Kleinridders A., Wunderlich F.T., et al. VKORC1 deficiency in mice causes early postnatal lethality due to severe bleeding. Thromb Haemost 101 (2009) 1044-1050
38. Zhang Y.P., Deng F.Y., Chen Y., et al. Replication study of candidate genes/loci associated with osteoporosis based on genome-wide screening. Osteoporos Int 21 (2010) 785-795